HLA-DRB1*1502 confers susceptibility to ulcerative colitis, but is negatively associated with its intractability: A Korean study

International Journal of Colorectal Disease

Volumn 17, Issue 4, 2002, Pages 233-237

  Myung, Seung Jae ^a   Yang, Suk Kyun ^a   Jung, Hwoon Yong ^a   Chang, Hye Sook ^a   Park, Jong Beom ^a   Hong, Weon Seon ^a   Kim, Jin Ho ^a   Min, Yong Il ^a  

^a University of Ulsan College of Medicine   (South Korea)

Author keywords

Anti neutrophil cytoplasmic antibody; Genetics; HLA; Ulcerative colitis

Indexed keywords

HLA ANTIGEN CLASS 2; HLA DR ANTIGEN; HLA DR2 ANTIGEN; NEUTROPHIL CYTOPLASMIC ANTIBODY; HLA-DRB1 ANTIGEN;

ADOLESCENT; ADULT; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE PREDISPOSITION; FEMALE; FREQUENCY ANALYSIS; GENETIC ANALYSIS; GENOTYPE; HUMAN; HYBRIDIZATION; MAJOR CLINICAL STUDY; MALE; OLIGONUCLEOTIDE PROBE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROCTOCOLECTOMY; SCHOOL CHILD; SOUTH KOREA; SURGICAL RISK; ULCERATIVE COLITIS; CASE CONTROL STUDY; COLON RESECTION; GENETIC PREDISPOSITION; GENETICS; IMMUNOLOGY; KOREA;

ADULT; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; CASE-CONTROL STUDIES; COLECTOMY; COLITIS, ULCERATIVE; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HLA-DR ANTIGENS; HUMANS; KOREA; MALE; POLYMERASE CHAIN REACTION;

EID: 0036882062     PISSN: 01791958     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00384-001-0381-4     Document Type: Article

References (33)

1. Yang H, Rotter JI (1998) Genetics of inflammatory bowel disease. In: Targan SR, Shanahan F (eds) Inflammatory bowel disease: from bench to bedside. Williams & Wilkins, Baltimore, pp 32-64
2. Satsangi J, Parkes M, Louis E, Hashimoto L, Kato N, Welsh K, Terwilliger JD, Lathrop GM, Bell JI, Jewell DP (1996) Two-stage genome-wide search in inflammatory bowel disease provides evidence for susceptibility loci on chromosomes 3, 7, and 12. Nat Genet 14:199-202
3. Ma Y, Ohmen J, Li Z (1999) A genome wide search identifies potential new susceptibility loci for Crohn's disease. Inflamm Bowel Dis 5:271-278
4. Stokkeres PCF, Reitsma PH, Tytgat GNJ, van Deventer SJH (1999) HLA-DR and -DQ phenotypes in inflammatory bowel disease: a meta-analysis. Gut 45:395-401
5. Ahmad T, Satsangi J, Mcgovern D, Bunce M, Jewell DP (2001) The genetics of inflammatory bowel disease. Aliment Pharmacol Ther 15:731-748
6. Duerr RH (1996) Genetics of inflammatory bowel disease. Inflamm Bowel Dis 2:48-60
7. Jewell DP (1998) Ulcerative colitis and Crohn's disease - susceptibility genes and clinical patterns. J Gastroenterol 33:458-462
8. Toyoda H, Wang SJ, Yang HY, Redford A, Magalong D, Tyan D, McElree CK, Pressman SR, Shanahan F, Targan SR, Rotter JI (1993) Distinct association of HLA class II genes with inflammatory bowel disease. Gastroenterology 104:741-748
9. Yoshitake S, Kimura A, Okada M, Yao T, Sasazuki T (1999) HLA class II alleles in Japanese patients with inflammatory bowel disease. Tissue Antigens 53:350-358
10. Masuda H, Nakamura Y, Tanaka T, Hayakawa S (1994) Distinct relationship between HLA-DR genes and intractability of ulcerative colitis. Am J Gastroenterol 89:1957-1962
11. Pena AS (1998) Genetics of inflammatory bowel disease. Dig Dis 16:356-363
12. De La Concha EG, Fernandez-Arquero M, Santa-Cruz S, Lopez-Nava G, Figueredo MA, Diaz-Rubio M, Garcia-Peredes J (1997) Positive and negative associations of distinct HLA-DR2 subtypes with ulcerative colitis (UC). Clin Exp Immunol 108:392-395
13. Satsangi J, Welsh KI, Bunce M, Juliet C, Farrant JM, Bell JI, Jewell DP (1996) Contribution of genes of the major histocompatibility complex to susceptibility and disease phenotype in inflammatory bowel disease. Lancet 347:1212-1217
14. Cottone M, Bunce M, Taylor CJ, Ting A, Jewell DP (1985) Ulcerative colitis and HLA phenotype. Gut 26:952-954
15. Park MH, Hwang YS, Park KS, Tokunaga K, Akaza T, Juji T, Kim SI (1997) HLA haplotypes in Koreans based on 107 families. Tissue Antigens 51:347-355
16. Kim SJ, Nisperos B, Mickelson E, Choi IH, Dahlberg S, Kim JD, Giblett ER, Hansen JA (1986) The HLA system in the Korean population. Hum Immunol 17:259-272
17. Anonymous (1988) Antineutrophil cytoplasm antibodies. Proceedings of the 1st International Workshop on ANCA. Copenhagen. APMIS Suppl 6:1-49
18. Yang YS, Kim DW (1996) Evaluation of a commercial kit "INNO-LiPA HLA DRB" for HLA-DR genotyping. Korean J Clin Pathol 16:228-237
19. Stokkers PCF, Camoglio L, van Deventer SJH (1996) Tumor necrosis factor (TNF) in inflammatory bowel disease: gene polymorphisms, animal models, and potential for anti-TNF therapy. J Inflamm 47:97-103
20. Juli T, Hagino Y, Tamaru M, Okochi K (1973) A possibly new Japanese specific HLA antigen (J-1). Jpn J Exp Med 43:447
21. Baur MP, Danilovs JA (1980) Population analysis of HLA-A, B, C, DR and other genetic markers. In: Terasaki PI (ed) Histocompatibility testing. UCLA Press, Los Angeles, pp 995-993
22. Hawkins BR (1983) Analysis of gene and haplotype frequencies in Caucasians, Japanese, and Chinese based on 2nd Asia-Oceania Histocompatibility Workshop data. In: Simons MJ, Tait BD (eds) Proceedings of the Second Asia and Oceania Histocompatibility Workshop Conference. Victoria, pp 193-220
23. Kobayashi K, Atoh M, Konoeda Y, Yagita A, Inoko H, Sekiguchi S (1990) HLA-DR, DQ and T cell antigen receptor constant beta genes in Japanese patients with ulcerative colitis. Clin Exp Immunol 80:400-403
24. Sugimura K, Asakura H, Mizuki N, Inoue M, Hibi T, Yagita A, Tsuji K, Inoko H (1993) Analysis of genes within the HLA region affecting susceptibility to ulcerative colitis. Hum Immunol 36:112-118
25. Asakura H, Tsuchiya M, Aiso S, Watanabe M, Kobayashi K, Hibi T, Ando K, Takata H, Sekiguchi S (1982) Association of the human lymphocyte DR2 antigen with Japanese ulcerative colitis. Gastroenterology 82:413-418
26. Futami S, Aoyama N, Honsako Y, Tamura T, Morimoto S, Nakashima T, Ohmoto A, Miyamoto M, Inaba H (1995) HLA-DRB1*1502 allele, subtype of DR15, is associated with susceptibility to ulcerative colitis and its progression. Dig Dis Sci 40:814-818
27. Saxon A, Shanahan F, Landers C, Ganz T, Targan SR (1990) A distinct subset of antineutrophil cytoplasmic antibodies is associated with inflammatory bowel disease. J Allergy Clin Immunol 86:202-210
28. Cambridge G, Rampton DS, Stevens TRJ, McCarthy DA, Kamm M, Leaker B (1992) Anti-neutrophil antibodies in inflammatory bowel disease: prevalence and diagnostic role. Gut 33:657-662
29. Shanahan F, Duerr RH, Rotter JI, Yang H, Sutherland LR, McElree C, Landers CJ, Targan SR (1992) Neutrophil autoantibodies in ulcerative colitis: familial aggregation and genetic heterogeneity. Gastroenterology 103:456-461
30. Kim WH, Choi PM, Landers CJ, Targan SR (1995) Role of antineutrophil cytoplasmic antibodies in an ethnically distinct population: Korean patients with ulcerative colitis. Am J Gastroenterol 90:1953-1958
31. Yang H, Rotter JI, Toyoda H, Landers C, Tyan D, McElree CK, Targan SR (1993) Ulcerative colitis: a genetically heterogeneous disorder defined by genetic (HLA class II) and subclinical (antineutrophil cytoplasmic antibodies) markers. J Clin Invest 92:1080-1084
32. Duerr RH, Neigut DA (1995) Molecularly defined HLA-DR2 alleles in ulcerative colitis and an antineutrophil cytoplasmic antibody-positive subgroup. Gastroenterology 108:423-427
33. Lee YT, Sung JJY, Poon P, Lai KN, Li PKT (1998) Association of HLA class II genes and anti-neutrophil cytoplasmic antibodies in Chinese patients with inflammatory bowel disease. Scand J Gastroenterol 33:623-627